G01N 33/6893
Related to diseases not provided for elsewhere
Official title: {related to diseases not provided for elsewhere}
G01N33/6893 (Related to diseases not provided for elsewhere) appears on 6,543 US grants and 13,823 published applications in this corpus.
Search patents in G01N- Granted patents
- 6,543
- Published applications
- 13,823
- Assignees
- 4,522
- Inventors
- 23,821
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 6 | 0 |
| 1988 | 6 | 0 |
| 1989 | 8 | 0 |
| 1990 | 9 | 0 |
| 1991 | 5 | 0 |
| 1992 | 25 | 0 |
| 1993 | 35 | 0 |
| 1994 | 26 | 0 |
| 1995 | 31 | 0 |
| 1996 | 32 | 0 |
| 1997 | 43 | 0 |
| 1998 | 110 | 0 |
| 1999 | 86 | 0 |
| 2000 | 87 | 0 |
| 2001 | 98 | 31 |
| 2002 | 89 | 238 |
| 2003 | 102 | 381 |
| 2004 | 84 | 384 |
| 2005 | 94 | 454 |
| 2006 | 148 | 485 |
| 2007 | 165 | 458 |
| 2008 | 142 | 392 |
| 2009 | 167 | 501 |
| 2010 | 251 | 549 |
| 2011 | 254 | 603 |
| 2012 | 231 | 521 |
| 2013 | 302 | 822 |
| 2014 | 285 | 735 |
| 2015 | 307 | 642 |
| 2016 | 315 | 663 |
| 2017 | 349 | 642 |
| 2018 | 356 | 609 |
| 2019 | 362 | 599 |
| 2020 | 344 | 583 |
| 2021 | 333 | 657 |
| 2022 | 281 | 646 |
| 2023 | 236 | 577 |
| 2024 | 244 | 628 |
| 2025 | 274 | 581 |
| 2026 | 212 | 442 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions, methods and kits for treating complement related disorders6 Oct 2026US 12,751,993 B2Trustees of Tufts College
- ß-amyloid cyclic ribonucleic acid, polypeptide, and application thereof6 Oct 2026US 12,753,215 B2
- Integrated method for urinary prostate specific Antigen N-glycosylation profiling by capillary electrophoresis6 Oct 2026US 12,754,163 B2Pannon Egyetem
- Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability29 Sep 2026US 12,746,255 B2Societe des Produits Nestle S. A.
- Tau-binding antibodies29 Sep 2026US 12,747,288 B2Ucb Biopharma Srl
- Methods of determining glucose hypometabolism-induced energy crisis and treatments thereof8 Oct 2026US 2026/0306018 A1Senovia Biosciences LLC
- Psma specific binding proteins for cancer diagnosis and treatment8 Oct 2026US 2026/0306582 A1Navigo Proteins GmbH
- Method for isolating fetuin-a8 Oct 2026US 2026/0308213 A1PreviPharma GmbH
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- Compositions and methods for detection of aberrant cdk5 expression8 Oct 2026US 2026/0309712 A1Arizona Board of Regents on Behalf of the University of Arizona
Most cited
By later US patents
- Technique for extracorporeal treatment of blood460US 5,910,252 ACobe Laboratories, Inc. · 1999
- Non-uniform channel junction-less transistor423US 8,487,378 B2Taiwan Semiconductor Manufacturing Company.Ltd · 2013
- Polypeptide marker for Alzheimer's disease and its use for diagnosis318US 4,666,829 AUniversity of California · 1987
- Methods for the detection of soluble .beta.-amyloid peptide244US 5,593,846 AAthena Neurosciences, Inc. · 1997
- Methods for early detection of heart disease231US 6,210,976 B1Medlyte Diagnostics, Inc. · 2001